Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05468463 · ClinicalTrials.gov registry record · NA
Promoting Increases in Living Donation Via Tele-navigation (PILOT)
A NA study of Kidney Diseases, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 347
- Enrollment target
- 1
- Study location
NCT05468463: Active NA study of Kidney Diseases, sponsored by University of Alabama at Birmingham.
NCT05468463 is a NA study of Kidney Diseases that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 347 participants, below the 1,776-participant average among 38 other Kidney Diseases trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05468463, a NA study of Kidney Diseases, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 347 participants
- Enrollment target
- 1
- Study location
Study Summary
We hypothesize that expansion of the Living Donor Navigator (LDN) program to include tele-health delivery will overcome geographic disparities in access and facilitate sustained increases in living donation. We will utilize an individually randomized group trial (IRGT) design with delayed intervention initiation to compare the effectiveness of tele-health LDN model to standard of care.
Primary Outcome
The number of living donors screened on behalf of transplant candidates will be collected/ identified through the electronic medical record system.
Conditions Studied
Interventions
- BEHAVIORAL Living Donor Navigator Program
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT05468463 still lists
NCT05468463 is an interventional study that assigns participants to a tested intervention. The registered 347 participants enrollment target is mid-sized for trials with a published cap, below the 1,776-participant average among 38 other Kidney Diseases trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Living Donor Navigator Program is the first listed.
NCT05468463 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05468463 about?
NCT05468463 is a clinical study titled "Promoting Increases in Living Donation Via Tele-navigation (PILOT)". We hypothesize that expansion of the Living Donor Navigator (LDN) program to include tele-health delivery will overcome geographic disparities in access and facilitate sustained increases in living donation. We will utilize an individually randomized group trial (IRGT) design with delayed interventi...
What is the current status of trial NCT05468463?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 347 participants. The study started on 2023-04-12. Estimated completion is 2026-07-31.
What conditions does trial NCT05468463 study?
This clinical trial studies the following conditions: Kidney Diseases.
What interventions are being tested in trial NCT05468463?
The interventions under investigation include: Living Donor Navigator Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05468463?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05468463 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05468463's enrollment target sits among peer trials
347 12th of 38 higher than 27 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- NCT04877522 · 347 participants · Phase 4
Asciminib Roll-over Study
- NCT05834660 · 347 participants · NA
SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
- NCT06963827 · 347 participants · Phase 3
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI